152 related articles for article (PubMed ID: 8898050)
21. Percutaneous absorption of pimecrolimus is not increased in patients with moderate to severe atopic dermatitis when pimecrolimus cream 1% is applied under occlusion.
Thaçi D; Kaufmann R; Bieber T; Hanfland J; Hauffe S; Koehne-Voss S; Waldmeier F
Dermatology; 2010; 221(4):342-51. PubMed ID: 21099191
[TBL] [Abstract][Full Text] [Related]
22. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety considerations in topical treatments for atopic dermatitis.
Nicol NH
Pediatr Nurs; 2011; 37(6):295-301; quiz 302. PubMed ID: 22256690
[TBL] [Abstract][Full Text] [Related]
24. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis.
Furue M; Terao H; Moroi Y; Koga T; Kubota Y; Nakayama J; Furukawa F; Tanaka Y; Katayama I; Kinukawa N; Nose Y; Urabe K
J Dermatol; 2004 Apr; 31(4):277-83. PubMed ID: 15187322
[TBL] [Abstract][Full Text] [Related]
25. The treatment of atopic dermatitis with topical immunomodulators.
Tomi NS; Luger TA
Clin Dermatol; 2003; 21(3):215-24. PubMed ID: 12781439
[No Abstract] [Full Text] [Related]
26. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
Onumah N; Kircik L
J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
[TBL] [Abstract][Full Text] [Related]
27. Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option?
Westland T; de Bruin-Weller MS; Van der Lelij A
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1187-9. PubMed ID: 23106347
[No Abstract] [Full Text] [Related]
28. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
[TBL] [Abstract][Full Text] [Related]
29. Topical immunomodulators for atopic dermatitis.
Bernard LA; Eichenfield LF
Curr Opin Pediatr; 2002 Aug; 14(4):414-8. PubMed ID: 12130904
[No Abstract] [Full Text] [Related]
30. Topical tacrolimus for atopic dermatitis: euphoria and vigilance.
Lübbe J
Dermatology; 2001; 203(1):1-2. PubMed ID: 11549790
[No Abstract] [Full Text] [Related]
31. Labial melanotic macule after application of topical tacrolimus: two case reports.
Zattra E; Albertin C; Belloni Fortina A
Acta Derm Venereol; 2010 Sep; 90(5):527. PubMed ID: 20814635
[No Abstract] [Full Text] [Related]
32. [Topical calcineurin inhibitors in atopic eczema -- pro].
Wollenberg A
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1614. PubMed ID: 16823713
[No Abstract] [Full Text] [Related]
33. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
34. [New immune suppressants: topical immunomodulatory agents].
Senatorski G; Sułowicz W; Paczek L
Przegl Lek; 2002; 59(11):907-11. PubMed ID: 12715720
[TBL] [Abstract][Full Text] [Related]
35. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus.
Am J Health Syst Pharm; 2001 Dec; 58(24):2376-7. PubMed ID: 11794952
[No Abstract] [Full Text] [Related]
37. [Tacrolimus ointment for the treatment of atopic dermatitis].
Ohtsuki M
Arerugi; 2009 May; 58(5):499-506. PubMed ID: 19487830
[No Abstract] [Full Text] [Related]
38. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
Kirsner RS; Heffernan MP; Antaya R
Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
[TBL] [Abstract][Full Text] [Related]
40. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
